Moody’s Negative on Isagen
Moody’s has revised the outlook on Isagen’s Baa3 rating to negative from stable, it says. The move is based on the government of Colombia’s decision to sell...
Already have an account?
Subscribe now for unlimited access to all current and archive news, data and market analysis.
Take a free two-week trial now for the latest news, data and market analysis.